In the latest trading session, 0.53 million Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares changed hands as the company’s beta touched 1.47. With the company’s most recent per share price at $20.48 changing hands around $2.68 or 15.04% at last look, the market valuation stands at $140.84M. TNXP’s current price is a discount, trading about -3181.25% off its 52-week high of $672.00. The share price had its 52-week low at $6.76, which suggests the last value was 66.99% up since then. When we look at Tonix Pharmaceuticals Holding Corp’s average trading volume, we note the 10-day average is 1.28 million shares, with the 3-month average coming to 1.69 million.
Analysts gave the Tonix Pharmaceuticals Holding Corp (TNXP) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended TNXP as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Instantly TNXP is in green as seen in intraday trades today. With action 17.35%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -37.91%, with the 5-day performance at 17.35% in the green. However, in the 30-day time frame, Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) is 52.02% up. Looking at the short shares, we see there were 0.88 million shares sold at short interest cover period of 0.56 days.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 46.06%. The 2025 estimates are for Tonix Pharmaceuticals Holding Corp earnings to increase by 93.27%.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
The share float percentage for the stock currently stands at 2.54%.
Among Mutual Funds, the top two as of Feb 28, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund. With 10.23 shares estimated at $0.22 million under it, the former controlled 0.16% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Total Market Index Fund held about 0.06% of the shares, roughly 4.02 shares worth around $84617.0.
